Pharmaceutical firms’ liquidity conditions remain sound

Listed drug firms’ liquidity conditions remained firm in June as companies are set to issue more corporate bonds and increase borrowings as part of efforts to secure capital on worries the ongoing uncertainty will continue due to the government’s plan to cut generic drug prices by up to 14 percent starting next April.

Liquidity ratio means a class of financial metrics that is used to determi...